A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

NCT03971071 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: Erenumab 70 mg
DRUG: Erenumab 140 mg
DRUG: Placebo

Sponsor

Amgen